Conferences
Advertisement
Last year, the research team presented on the reliability of the measure, while this year's presentation focused on validity.
The program will feature nursing perspectives on patient access, finances in cancer care, and holistic self-care for nurses.
Teresa Hagan Thomas, PhD, RN, shares key tips and advice for getting the most out of ONS Congress this spring.
Learn how ACCESS study data is informing patient-centered GVHD care and eliminating the donor access barrier for HSCT trials.
Martha Raymond, MA, of the GI Cancers Alliance, shares insights from a yearlong study that gathered patient perspectives.
Stephen R. Spellman shares highlights from the results of the ACCESS trial, which was presented at the 2025 Tandem Meetings.
A recent survey provides key insights into patient experiences with MIBC treatment and diagnosis over the past decade.
Krystal Waldrup, BSN, RN, OCN, shares how the training improved nurse confidence and opened up capacity in the oncology unit.
Anna Barata, PhD, shares key insights from the CAR-T research that she presented during the 2025 Tandem Meetings.
The Tandem Transplantation and Cellular Therapy Meetings offer a dedicated nursing track, networking opportunities, and more.
Chelsea Honstain, NP, is vice chair of the APP Steering Committee and chair of the Education Subcommittee.
The Tandem Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR are taking place February 12-15.
Partially hydrolyzed guar gum, a soluble dietary fiber obtained from guar beans, was evaluated due to its butyrate content.
The Lee Symptom Scale for skin sclerosis was informed by patient interviews and feedback.
Martha Raymond, MA, founder of the GI Cancers Alliance, shares insights from her recent presentation on the programming.
Study investigators say the blood-based test has the potential to improve screening rates.
The questions on the quiz assess personal and family history, along with hereditary syndromes and demographics.
Researchers presented data from the program during the American Society of Clinical Oncology GI Cancer Symposium.
Researchers explored the real-world outcomes and management strategies in patients receiving the antibody-drug conjugate.
Learn how oral dysbiosis correlates with exacerbated cGVHD in patients after receiving hematopoietic cell transplantation.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.